BUTASYL Injectable Solution

Nonsteroidal anti-inflammatory, analgesic, antipyretic

in solution for injection

Laboratory

ZOETIS SPAIN, SLU

Pharmaceutical form

Solution for injection (Sol.i.)

Composition per ml:

Phenylbutazone 186.1 mg; 50.0 mg sodium salicylate.

Interactions and incompatibilities

Do not administer with other analgesics, corticosteroids, barbiturates, chloramphenicol, sulfonamides,

anticoagulants, hydantoin-type anticonvulsants and hypoglycemic agents.

Indications and target species

Equine: Acute arthritis.

Contraindications of Butasyl

• Do not use in animals with cardiorenal conditions, edema, gastritis or hemoglobinuria.

• Do not use in case of hypersensitivity to nonsteroidal anti-inflammatory drugs.

Side effects

Very rarely digestive disorders ( colic gastritis , diarrhea) may occur ;

depression and anorexia; blood dyscrasias, decreased platelet aggregation (petechiae,

hemorrhages) and phlebopathies, as well as hydrosaline retention (edema). At the first symptom it is advised

stop treatment

Route of administration

Slow intravenous.

Posology

Equine:

Initial dose (adult animal and foals): 4 ml / 100 kg at 12-hour intervals.

Maintenance dose (adult animal and foals): 2 ml / 100 kg at 12-hour intervals.

Duration of treatment: 4 6 days depending on the inflammatory process.

Special precautions of Butasyl

• During the treatment period it is recommended to establish a hypoprotein regime,

reducing the contribution of chlorides since there is a risk of edema formation.

• Do not administer to horses at least eight days before participating in a competition.

Wait time

Do not use in equines whose meat or milk is intended for human consumption.

Conservation mode of Butasyl

Store and transport refrigerated (between 2 and 8 ° C). Protect from direct sunlight.

Observations

With veterinary prescription.

Presentation of Butasyl

100 ml bottle

Reg. Nº

2101 ESP